Clinical Trial Update: MTX Hold During Covid-19 Booster [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating hold of methotrexate during COVID-19 booster in rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Seoul National University Hospital | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN